InvestorsHub Logo
Followers 53
Posts 3607
Boards Moderated 0
Alias Born 03/02/2008

Re: JohnTrades post# 4921

Friday, 03/22/2024 8:28:25 AM

Friday, March 22, 2024 8:28:25 AM

Post# of 6960
This is just a section of your post that I clipped to be recognized.


Item 8.01. Other Events.
On March 20, 2024, the Company issued a press release to announce that it had signed a binding term sheet covering the exclusive license and commercialization agreement for the Company's FDA-approved prescription drug Crofelemer with Purchaser in certain countries within Eastern Europe (the "Licensing Transaction"), which press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JAGX News